Prevention of Serious Adverse Events Following Angiography

Completed · Phase 3 · Has a placebo group

Conditions studied: Acute Renal Failure, Kidney Disease, Coronary Artery Disease

In brief

The purpose of this research study is to compare the effectiveness of intravenous isotonic sodium bicarbonate with intravenous isotonic sodium chloride and oral N-acetylcysteine (NAC) with oral placebo for the prevention of serious adverse outcomes following angiographic procedures in high-risk patients.

Key facts

Study ID
NCT01467466
Run by
VA Office of Research and Development
People needed
5177
Starts
2013-10-07
Expected to finish
2017-10-17
Last updated by the study team
2025-11-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.